BRD2 and amenorrhea: Several studies have suggested low or no risk of amenorrhea [30,31,32,33,34], whereas other studies reported gonadal toxicity as indicated by high follicle stimulating hormone (FSH) levels [9] and an increasing risk of amenorrhea [32,35].